Compare GRANULES INDIA with Cadila Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GRANULES INDIA vs CADILA HEALTHCARE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GRANULES INDIA CADILA HEALTHCARE GRANULES INDIA/
CADILA HEALTHCARE
 
P/E (TTM) x 16.9 18.3 92.2% View Chart
P/BV x 3.7 3.3 112.1% View Chart
Dividend Yield % 0.5 0.8 56.0%  

Financials

 GRANULES INDIA   CADILA HEALTHCARE
EQUITY SHARE DATA
    GRANULES INDIA
Mar-21
CADILA HEALTHCARE
Mar-21
GRANULES INDIA/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs438509 86.0%   
Low Rs138259 53.4%   
Sales per share (Unadj.) Rs130.7147.5 88.6%  
Earnings per share (Unadj.) Rs22.220.9 106.2%  
Cash flow per share (Unadj.) Rs28.328.0 101.2%  
Dividends per share (Unadj.) Rs1.503.50 42.9%  
Avg Dividend yield %0.50.9 57.1%  
Book value per share (Unadj.) Rs86.8126.9 68.4%  
Shares outstanding (eoy) m247.671,023.74 24.2%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.22.6 84.7%   
Avg P/E ratio x13.018.4 70.6%  
P/CF ratio (eoy) x10.213.7 74.1%  
Price / Book Value ratio x3.33.0 109.6%  
Dividend payout %6.816.8 40.3%   
Avg Mkt Cap Rs m71,337393,092 18.1%   
No. of employees `000NANA-   
Total wages/salary Rs m3,24322,548 14.4%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m32,375151,022 21.4%  
Other income Rs m269449 59.9%   
Total revenues Rs m32,644151,471 21.6%   
Gross profit Rs m8,55231,335 27.3%  
Depreciation Rs m1,5157,248 20.9%   
Interest Rs m2631,688 15.6%   
Profit before tax Rs m7,04422,848 30.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5491,472 105.2%   
Profit after tax Rs m5,49521,376 25.7%  
Gross profit margin %26.420.7 127.3%  
Effective tax rate %22.06.4 341.4%   
Net profit margin %17.014.2 119.9%  
BALANCE SHEET DATA
Current assets Rs m19,97087,160 22.9%   
Current liabilities Rs m11,73178,613 14.9%   
Net working cap to sales %25.45.7 449.7%  
Current ratio x1.71.1 153.5%  
Inventory Days Days1633 49.0%  
Debtors Days Days86376 1,141.7%  
Net fixed assets Rs m17,157140,943 12.2%   
Share capital Rs m2481,024 24.2%   
"Free" reserves Rs m21,262128,899 16.5%   
Net worth Rs m21,510129,923 16.6%   
Long term debt Rs m3,4116,095 56.0%   
Total assets Rs m37,127228,103 16.3%  
Interest coverage x27.814.5 191.2%   
Debt to equity ratio x0.20 338.1%  
Sales to assets ratio x0.90.7 131.7%   
Return on assets %15.510.1 153.4%  
Return on equity %25.516.5 155.3%  
Return on capital %29.318.0 162.5%  
Exports to sales %81.90-   
Imports to sales %26.810.5 254.8%   
Exports (fob) Rs m26,528NA-   
Imports (cif) Rs m8,69115,911 54.6%   
Fx inflow Rs m26,52863,535 41.8%   
Fx outflow Rs m8,69115,911 54.6%   
Net fx Rs m17,83747,624 37.5%   
CASH FLOW
From Operations Rs m4,32532,930 13.1%  
From Investments Rs m-2,771-7,225 38.4%  
From Financial Activity Rs m-2,993-25,489 11.7%  
Net Cashflow Rs m-1,441-905 159.2%  

Share Holding

Indian Promoters % 41.6 74.9 55.6%  
Foreign collaborators % 0.4 0.0 -  
Indian inst/Mut Fund % 25.7 15.7 164.2%  
FIIs % 21.4 3.8 564.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 58.0 25.1 231.0%  
Shareholders   216,385 370,931 58.3%  
Pledged promoter(s) holding % 7.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GRANULES INDIA With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Sensex Tanks 554 Points, Nifty Ends Near 18,100; Maruti, Tech Mahindra & Tata Consumer Plunge 4%(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views on News

GRANULES INDIA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of GRANULES INDIA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GRANULES INDIA. Also includes updates on the valuation of GRANULES INDIA.

CADILA HEALTHCARE Announces Quarterly Results (1QFY22); Net Profit Up 35.0% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, CADILA HEALTHCARE has posted a net profit of Rs 6 bn (up 35.0% YoY). Sales on the other hand came in at Rs 40 bn (up 14.5% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

Cadila Healthcare Reports 73% Rise in Profits (Views On News)

May 28, 2021

A look into the company's quarter four financial performance.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Looking for Consistent Compounding Stocks? Here's a Watchlist for You(Views On News)

Jan 6, 2022

These companies have generated mind boggling returns for investors over the years.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GRANULES INDIA SHARE PRICE


Jan 18, 2022 (Close)

TRACK GRANULES INDIA

  • Track your investment in GRANULES INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GRANULES INDIA

GRANULES INDIA - ZENITH HEALTH COMPARISON

COMPARE GRANULES INDIA WITH

MARKET STATS